FDA Approved: HEMLIBRA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hemlibra (emicizumab) from Genentech, Inc., updating the labeling to reflect the approved supplemental action.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Hemlibra (emicizumab)

Snippet

SUPPL AP for HEMLIBRA (EMICIZUMAB)